Valoron



Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 26.8%
Hypertension 17.3%
Pain 13.4%
Drug Use For Unknown Indication 8.7%
Schizophrenia 4.7%
Prophylaxis Against Gastrointestinal Ulcer 3.9%
Restless Legs Syndrome 3.9%
Analgesic Therapy 3.1%
Cerebrovascular Accident 3.1%
Rheumatoid Arthritis 3.1%
Type 2 Diabetes Mellitus 3.1%
Breast Cancer Metastatic 1.6%
Hyperuricaemia 1.6%
Cancer Pain 0.8%
Depression 0.8%
Extrapyramidal Disorder 0.8%
Marasmus 0.8%
Metastatic Pain 0.8%
Pancreatic Carcinoma 0.8%
Polyarthritis 0.8%
Somnolence 20.0%
Suicide Attempt 20.0%
Accidental Exposure 8.0%
Renal Failure Acute 8.0%
Drug Interaction 4.0%
Hypotension 4.0%
Inappropriate Schedule Of Drug Administration 4.0%
Multiple Drug Overdose Intentional 4.0%
Pruritus 4.0%
Pulmonary Oedema 4.0%
Rheumatoid Arthritis 4.0%
Thyroid Neoplasm 4.0%
Vestibular Neuronitis 4.0%
Visual Acuity Reduced 4.0%
Vomiting 4.0%
Concomitant
Product Used For Unknown Indication 35.0%
Rheumatoid Arthritis 18.2%
Pain 8.8%
Drug Use For Unknown Indication 6.7%
Hypertension 4.5%
Prophylaxis 3.4%
B-cell Lymphoma 2.6%
Osteoporosis 2.3%
Breast Cancer 2.2%
Multiple Myeloma 2.2%
Depression 2.1%
Psoriatic Arthropathy 2.1%
Restless Legs Syndrome 1.7%
Diabetes Mellitus 1.4%
Chronic Obstructive Pulmonary Disease 1.3%
Crohn's Disease 1.3%
Non-small Cell Lung Cancer 1.3%
Polyarthritis 1.1%
Thrombosis Prophylaxis 1.1%
Premedication 0.9%
Galactorrhoea 9.6%
Pulmonary Embolism 8.5%
General Physical Health Deterioration 7.4%
Thrombocytopenia 7.4%
Vomiting 7.4%
Hepatitis Cholestatic 5.3%
Nausea 5.3%
Pupils Unequal 5.3%
Anaemia 4.3%
Circulatory Collapse 4.3%
Hepatotoxicity 4.3%
Sepsis 4.3%
Syncope 4.3%
Female Genital Tract Fistula 3.2%
Hip Surgery 3.2%
Pancreatitis Acute 3.2%
Pyrexia 3.2%
Thrombosis 3.2%
Tooth Fracture 3.2%
Trigeminal Neuralgia 3.2%
Interacting
Hypertension 45.5%
Pain 18.2%
Cerebrovascular Accident 9.1%
Hyperuricaemia 9.1%
Prophylaxis Against Gastrointestinal Ulcer 9.1%
Type 2 Diabetes Mellitus 9.1%
Constipation 100.0%